- How the pandemic impacted the structure and responsiveness of our global networks
- Responding to new geographic fluctuation of demand by disease states and patient delivery
- The challenges and opportunities posed by new product innovation and managing lifecycles
—
SVP Global Supply Chain and Strategy
AstraZeneca
Linzell Harris is senior vice president of Global Supply Chain and Strategy for AstraZeneca, with overall responsibility for the development and execution of the end to end supply chain platform and product supply strategies. In addition, he is responsible for ensuring the strategic development of network designs and supply chain capabilities supporting the global AZ operational network.
Reporting into the EVP of Operations and Information Technology, Linzell is a member of the Global Operations Senior Leadership Team.
Linzell has more than 30 years of diverse general management and global operations experience in the consumer product goods, pharmaceutical and luxury goods industries.
Prior to joining AstraZeneca, Linzell held the role of Senior Vice President, Global Supply Chain for TEVA Pharmaceuticals – supporting the company’s comprehensive global supply network for generic and specialty pharmaceuticals. Before TEVA, he served as Head of Global Operations for Godiva Chocolatier and as a member of Godiva’s Executive Leadership team reporting to the CEO and President.
Additionally, Linzell has worked in Senior Management roles at Johnson and Johnson, Pfizer, Warner Lambert and Baxter Healthcare. He began his working career as a Supply Corp officer in the US Navy.
Linzell earned a BS in Mathematics from the US Naval Academy in Annapolis, MD with graduate studies at Villanova University. He has completed executive studies at Michigan State, Columbia and Harvard Universities.
